Biomea Fusion, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3
Biomea Fusion, Inc. (BMEA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 · last filed 2026-08-05
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2026-06-30 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2026-03-31 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2025-12-31 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for the quarter ending 2025-09-30 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for fiscal 2025 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for fiscal 2024 was $0.00.
- Biomea Fusion, Inc. fair value, measurement with unobservable inputs reconciliation, liability, transfers out of level 3 for fiscal 2023 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-03-24 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $0.00 derived: sum of 3 quarters · filed 2026-03-24 | $0.00 10-K · filed 2026-03-24 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-08-05 | $0.00 derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-05 | $0.00 derived: sum of 2 quarters · filed 2025-05-05 | $0.00 derived: sum of 3 quarters · filed 2025-05-05 | $0.00 derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-30 | $0.00 derived: sum of 2 quarters · filed 2023-10-30 | $0.00 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-07-31 | $0.00 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |